The Clinical Study of Kang Ning Capsule in Reducing Liver Fibrosis
Zhu Ke
Abstract
Zhu Ke
Abstract
Objective:To investigate the effect of Kang Ning Capsule in reducing liver fibrosis. Method:The treatment group included 102 cases and the control group 78 cases.The serum hyaluronic acid(HA),Laminin(L),human procollagen Ⅲ(PC Ⅲ) and Ⅳ from both groups were determined and compared. Result:The decreases of serum HA, L,PC Ⅲ and PC Ⅳ in the treatment group were more significant than those in the control group. Conclusion:Kang Ning Capsule can reduce the liver fibrosis when used in the treatment of chronic hepatitis and cirrhosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of Kang Ning Capsule in reducing liver fibrosis. Method:The treatment group included 102 cases and the control group 78 cases.The serum hyaluronic acid(HA),Laminin(L),human procollagen Ⅲ(PC Ⅲ) and Ⅳ from both groups were determined and compared. Result:The decreases of serum HA, L,PC Ⅲ and PC Ⅳ in the treatment group were more significant than those in the control group. Conclusion:Kang Ning Capsule can reduce the liver fibrosis when used in the treatment of chronic hepatitis and cirrhosis.
Key concepts: Capsule, Hyaluronic acid, Procollagen peptidase, Cirrhosis, Fibrosis, Laminin, Medicine, Internal medicine